Yüklüyor......
Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
The antitumorigenic mechanism of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib is still a matter of debate. Using lung cancer cell lines (A549, H460) and metastatic cells derived from a lung cancer patient, the present study investigates the impact of celecoxib on the expression of inte...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4770776/ https://ncbi.nlm.nih.gov/pubmed/26513172 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|